ReviewHuman C-reactive protein: expression, structure, and function
Introduction
C-reactive protein (CRP) is a member of the phylogenetically ancient and highly conserved ‘pentraxin’ family of proteins, which also includes serum amyloid P component (SAP), a constituent of all amyloid deposits. In man and other animal species, CRP is a major acute-phase plasma protein displaying rapid and pronounced rise of its serum concentration in response to infection or tissue injury. CRP has Ca2+-dependent binding specificity for phosphocholine (PCh), a constituent of many bacterial and fungal polysaccharides and of most biological cell membranes (Volanakis and Kaplan, 1971). Indeed, CRP was discovered and named because of its reactivity with the PCh residues of C-polysaccharide (PnC), the teichoic acid of Streptococcus pneumoniae (Tillett and Francis, 1930). CRP also binds certain nuclear constituents, which do not contain PCh, such as small ribonucleoprotein particles (Du Clos, 1989, Pepys et al., 1994). Ligand-complexed CRP is recognized by C1q and efficiently activates the classical pathway of human complement (Kaplan and Volanakis, 1974, Volanakis, 1982a). Complexed CRP can also elicit responses from phagocytic cells through binding to the FcγRI and FcγRIIa receptors (Marnell et al., 1995, Bharadwaj et al., 1999). Its ability to recognize pathogens and to mediate their elimination by recruiting the complement system and phagocytic cells makes CRP an important constituent of the first line of innate host defense. Furthermore, the protein appears to play a role in the clearance of apoptotic and necrotic host cells, thus contributing to restoration of normal structure and function of injured tissues. Like other elements of immunity, CRP perhaps has not only protective, but also potentially harmful effects. Thus, recently CRP has been implicated in atherogenesis (Torzewski et al., 2000, Zwaka et al., 2001) and in the mediation of tissue damage in acute myocardial infarction (Griselli et al., 1999).
Section snippets
Regulation of expression
The swift rise of its serum concentration during the acute phase, the magnitude of the response approaching 1000-fold increase within 24–48 h, and the equally quick return to the very low normal concentration of a few μg/ml are the most impressive biologic characteristics of CRP. Expression of CRP is regulated mainly at the transcriptional level, but post-transcriptional mechanisms also play a significant role. The CRP gene has been mapped to human chromosome 1, between 1q21 and 1q23. It
Structure
The structure of CRP has been determined by X-ray crystallography at 3 Å resolution (Shrive et al., 1996, Thompson et al., 1999). Like SAP, the other pentraxin of known structure (Emsley et al., 1994), CRP consists of five noncovalently associated protomers arranged symmetrically around a central pore. The overall dimensions of the CRP pentamer are about 102 Å outside diameter with a central pore diameter of 30 Å and a protomer diameter of 36 Å. The protomer consists of 206 amino acids folded
Function
The main biologic function of CRP is determined by its ability to recognize pathogens and damaged cells of the host and to mediate their elimination by recruiting the complement system and phagocytic cells. PCh, the principal CRP ligand, is widely distributed in teichoic acids, capsular carbohydrates, and lipopolysaccharides of bacteria and other micro-organisms. Its presence has been reported in S. pneumoniae (Brundish and Baddiley, 1968), Haemophilus influenzae (Weiser et al., 1997),
References (100)
- et al.
Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis
J. Biol. Chem.
(1992) - et al.
C-reactive protein decreases protein phosphorylation in stimulated human neutrophils
FEBS Lett.
(1988) - et al.
Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
Cell
(1995) - et al.
C-reactive protein inhibits chemotactic peptide-induced p38 mitogen-activated protein kinase activity and human neutrophil movement
J. Biol. Chem.
(1999) - et al.
cis-Acting elements responsible for interleukin-6 inducible C-reactive protein gene expression
J. Biol. Chem.
(1990) - et al.
Secretion of C-reactive protein becomes more efficient during the course of the acute phase response
J. Biol. Chem.
(1985) - et al.
Two carboxylesterases bind C-reactive protein within the endoplasmic reticulum and regulate its secretion during the acute phase response
J. Biol. Chem.
(1994) - et al.
Enhanceosomes
Curr. Op. Gen. Dev.
(2001) - et al.
Regulation of complement activation by C-reactive protein
Immunopharmacology
(1999) - et al.
Regulation of the human C-reactive protein gene in transgenic mice
J. Biol. Chem.
(1995)
Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
Am. J. Cardiol.
Internalization and degradation of receptor bound C-reactive protein by U-937 cells: induction of H2O2 production and tumoricidal activity
Biochim. Biophys. Acta
The physiological structure of human C-reactive protein and its complex with phosphocholine
Structure
C-reactive protein as a marker for caridiac ischemic events in the year afer a first uncomplicated myocardical infarction
Am. J. Cardiol.
Binding of human C4 to C-reactive protein-pheumococcal C-polysaccharide complexes during activation of the classical complement pathway
Mol. Immunol.
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component
J. Biol. Chem.
Identification of a C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C-reactive protein within the endoplasmic reticulum
J. Biol. Chem.
STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6
J. Biol. Chem.
Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis
J. Immunol.
Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein. Role of Thr76 and Trp67
J. Immunol.
Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein β (C/EBPβ) and Rel p50
J. Immunol.
Topology and structure of the C1q-binding site on C-reactive protein
J. Immunol.
Activation of human monocyte tumoricidal activity by C-reactive protein
Cancer Res.
Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis
J. Immunol.
The major receptor for C-reactive protein on leukocytes is Fcγ receptor II
J. Exp. Med.
Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate
Biochem. J.
The Rel family member p50 mediates cytokine-induced C-reactive protein expression by a novel mechanism
J. Immunol.
Inducible and tissue-specific expression of human C-reactive protein in transgenic mice
EMBO J.
C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to FcγRI
J. Immunol.
Fc receptor biology
Ann. Rev. Immunol.
Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity
Arthritis Rheum.
Expression of C-reactive protein by alveolar macrophages
J. Immunol.
C-reactive protein reacts with the U1 small nuclear ribonucleoprotein
J. Immunol.
Analysis of the binding of C-reactive protein to histones and chromatin
J. Immunol.
A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae
J. Immunol.
Structure of pentameric human serum amyloid P component
Nature
Acute-phase proteins and other systemic responses to inflammation
N. Engl. J. Med.
C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages
J. Leukoc. Biol.
Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells
J. Immunol.
C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity
J. Exp. Med.
Localization of C-reactive protein in synovium of patients with rheumatoid arthritis
Arthritis Rheum.
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
J. Exp. Med.
A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells
Immunol. Today
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Lancet
Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis
Am. J. Pathol.
Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein
Am. J. Physiol.
In vitro effects of C-reactive protein on phagocytosis
J. Bacteriol.
Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8–11
J. Immunol.
C-reactive protein: a physiological activator of interleukin 6 receptor shedding
J. Exp. Med.
Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin
J. Immunol.
Cited by (728)
Dynamic changes in inflammatory responses and 3-year clinical outcomes of XINSORB scaffolds in coronary stenting
2024, Cardiovascular Revascularization MedicineRelationship between C-reactive protein and antipsychotics levels in schizophrenic patients infected with COVID-19
2024, Journal of Psychiatric ResearchPerformance evaluation of the LumiraDx quantitative microfluidic point-of-care CRP test
2024, Practical Laboratory MedicinePentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications
2023, Developmental and Comparative ImmunologyThe pentraxin family in autoimmune disease
2023, Clinica Chimica Acta